Twenty-three TAs seemed to be broadly expressed (RPKM > = 1 in more than 75% of the MRTs) while others (e.g., MAGEA4) showed prominent expression in only a subset of the tumor samples (Fig. 2C). The gene discussed is MAGEA4; the disease is neoplasm.